NOVEMBRINO, CRISTINA
NOVEMBRINO, CRISTINA
DIPARTIMENTO DI SCIENZE NEUROLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
Platelet function abnormalities in acquired hemophilia A
2026 R. Rossio, A. Lecchi, S. La Marca, L. Padovan, R. Gualtierotti, C. Novembrino, C. Suffritti, S. Arcudi, A. Ciavarella, F. Boggio, S.M. Siboni, F. Peyvandi
Discrepancies of results for post infusion levels of extended half-life factor VIII/IX concentrates – a cause of concern, awaiting for solution
2026 A. Tripodi, C. Novembrino, F. Peyvandi
Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis
2026 B. Fattizzo, M. Abbatista, N. Cecchi, C. Novembrino, M. Boscolo-Anzoletti, G.L. Pedone, M. Bortolotti, A. Artoni, J.A. Giannotta, F. Peyvandi, F. Passamonti, W. Barcellini, M. Capecchi
Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry
2025 A. Tripodi, M. Clerici, E. Scalambrino, S. Arcudi, R. Gualtierotti, C. Novembrino, F. Peyvandi
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
2022 M. Cugno, P.L. Meroni, D. Consonni, S. Griffini, E. Grovetti, C. Novembrino, A. Torri, G. Griffante, M. Gariglio, L. Varani, F. Peyvandi
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection
2021 A. Tripodi, E. Scalambrino, V. Chantarangkul, O. Paoletti, M. Clerici, C. Novembrino, M. Boscolo-Anzoletti, F. Peyvandi, S. Testa
Hemostatic alterations in COVID-19
2021 F. Peyvandi, A. Artoni, C. Novembrino, S. Aliberti, M. Panigada, M. Boscarino, R. Gualtierotti, F. Rossi, R. Palla, I. Martinelli, G. Grasselli, F. Blasi, A. Tripodi
Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma
2020 A. Tripodi, V. Chantarangkul, C. Novembrino, E. Scalambrino, M. Boscolo-Anzoletti, M. Clerici, F. Rossi, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A
2019 C. Novembrino, M. Boscolo Anzoletti, M.E. Mancuso, S. Shinohara, F. Payvandi
Rescue FVIII replacement to secure haemostasis in a patient with haemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement
2019 E. Santagostino, M.E. Mancuso, C. Novembrino, L.P. Solimeno, A. Tripodi, F. Peyvandi
Advances in the treatment of hemophilia: Implications for laboratory testing
2019 A. Tripodi, V. Chantarangkul, C. Novembrino, F. Peyvandi
In vitro correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate
2018 C. Bulato, C. Novembrino, M.B. Anzoletti, L. Spiezia, S. Gavasso, C. Berbenni, G. Tagariello, C. Farina, I. Nardini, E. Campello, F. Payvandi, P. Simioni
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
2018 I. Martinelli, M. Abbattista, P. Bucciarelli, A. Tripodi, A. Artoni, F. Gianniello, C. Novembrino, F. Peyvandi
Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study
2018 M. Panigada, G. Iapichino, M. Brioni, G. Panarello, A. Protti, G. Grasselli, G. Occhipinti, C. Novembrino, D. Consonni, A. Arcadipane, L. Gattinoni, A. Pesenti
Oxidative status in different settings and with different methodological approaches compared by Receiver Operating Characteristic curve analysis
2015 G. Cighetti, F. Bamonti, C.S. Aman, D. Gregori, C. Novembrino, F. De Liso, R. de Giuseppe, R. Maiavacca, R. Paroni
Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis
2015 F. De Liso, C. Matinato, C. Novembrino, A. Radice, F. Raffiotta, M. Ronchi, M.D. Croci, R.A. Sinico, P. Messa, E. Torresani, G. Moroni
Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock
2015 A. Protti, F. Fortunato, A. Artoni, A. Lecchi, G. Motta, G. Mistraletti, C. Novembrino, P. Comi, L. Gattinoni
Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients
2014 C. Novembrino, A. Aghemo, C. Ferraris Fusarini, R. Maiavacca, C. Matinato, G. Lunghi, E. Torresani, M. Ronchi, M.C. Garlaschi, M. Ramondetta, M. Colombo